{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:17:53Z","timestamp":1773296273874,"version":"3.50.1"},"reference-count":61,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.drugalcdep.2013.01.020","type":"journal-article","created":{"date-parts":[[2013,2,28]],"date-time":"2013-02-28T21:07:24Z","timestamp":1362085644000},"page":"172-181","source":"Crossref","is-referenced-by-count":38,"title":["Is the HCV\u2013HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmission?"],"prefix":"10.1016","volume":"132","author":[{"given":"Peter","family":"Vickerman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha K.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuradha","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara","family":"Beattie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Don Des","family":"Jarlais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffanie","family":"Strathdee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas","family":"Wiessing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Hickman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0005","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.epidem.2010.08.003","article-title":"HSV-2 serology can be predictive of HIV epidemic potential and hidden sexual risk behavior in the Middle East and North Africa","volume":"2","author":"Abu-Raddad","year":"2010","journal-title":"Epidemics"},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0010","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/01.aids.0000218543.46963.6d","article-title":"Risk of HIV-1 transmission for parenteral exposure and blood transfusion: a systematic review and meta-analysis","volume":"20","author":"Baggaley","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0015","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1258\/ijsa.2008.008362","article-title":"Systematic review of HIV and HCV infection among drug users in China","volume":"20","author":"Bao","year":"2009","journal-title":"Int. J. STD AIDS"},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0020","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1473-3099(12)70066-X","article-title":"Burden of HIV among female sex workers in low-income and middle-income countries: a systematic review and meta-analysis","volume":"12","author":"Baral","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0025","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0255-0857(21)03016-4","article-title":"A cross sectional serological study of the co-infection of hepatitis b virus, hepatitis c virus and human immunodeficiency virus amongst a cohort of idus at Delhi","volume":"21","author":"Baveja","year":"2003","journal-title":"Indian J. Med. Microbiol."},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0030","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S1473-3099(09)70021-0","article-title":"Heterosexual risk of HIV-1 infection per sexual act: a systematic review and meta-analysis of observational studies","volume":"9","author":"Boily","year":"2009","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0035","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.drugpo.2012.08.005","article-title":"An urgent need to scale-up injecting drug harm reduction services in Tanzania: prevalence of blood-borne viruses among drug users in Temeke District, Dar-es-Salaam, 2011","volume":"24","author":"Bowring","year":"2012","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0205","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/qjmed\/90.10.617","article-title":"Pre-AIDS deaths in HIV infection related to intravenous drug use","volume":"90","author":"Brettle","year":"1997","journal-title":"QJM"},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0040","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1590\/S0102-311X2006000400016","article-title":"The contribution of two Brazilian multi-center studies to the assessment of HIV and HCV infection and prevention strategies among injecting drug users: the AjUDE-Brasil I and II Projects","volume":"22","author":"Caiaffa","year":"2006","journal-title":"Cad. Saude Publica"},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0045","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa1105243","article-title":"Prevention of HIV-1 infection with early antiretroviral therapy","volume":"365","author":"Cohen","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0210","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1086\/428578","article-title":"Prospective evaluation of community-acquired acute-phase hepatitis C virus infection","volume":"40","author":"Cox","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0215","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1017\/S095026880900212X","article-title":"Incidence of hepatitis C in drug injectors: the role of homelessness, opiate substitution treatment, equipment sharing, and community size","volume":"137","author":"Craine","year":"2009","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0050","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/00126334-200104150-00011","article-title":"Relation between HIV-1 and hepatitis C viral load in patients with hemophilia","volume":"26","author":"Daar","year":"2001","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"Suppl. 2","key":"10.1016\/j.drugalcdep.2013.01.020_bib0055","first-page":"22","article-title":"Risk of hepatitis C virus transmission following percutaneous exposure in healthcare workers","volume":"31","author":"De Carli","year":"2003","journal-title":"Infection"},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0060","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.drugalcdep.2008.11.007","article-title":"Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City","volume":"101","author":"Des Jarlais","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0065","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.2105\/AJPH.2011.300130","article-title":"Associations between herpes simplex virus type 2 and HCV With HIV among injecting drug users in New York City: the current importance of sexual transmission of HIV","volume":"101","author":"Des Jarlais","year":"2011","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0220","unstructured":"Friedman, S., Curtis, R., Neaigus, A., Jose, B.Des Jarlais, D. (1999). Social Networks, Drug Injectors\u2019 Lives, and HIV\/AIDS. New York, Kluwer Academic\/Plenum Publishers."},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0070","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S1473-3099(12)70010-5","article-title":"Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine","volume":"12","author":"Grebely","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0225","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/jurban\/jtg030","article-title":"Mortality and fatal overdose risk - pilot cohort study of heroin users recruited from specialist drug treatment sites in London","volume":"90","author":"Hickman","year":"2003","journal-title":"J. Urban Health"},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0230","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2893.2007.00855.x","article-title":"Hepatitis C virus (HCV) prevalence, and injecting risk behaviour in multiple sites in England in 2004","volume":"14","author":"Hickman","year":"2007","journal-title":"J. Viral. Hepat."},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0075","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1086\/590501","article-title":"HIV-1 transmission, by stage of infection","volume":"198","author":"Hollingsworth","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0080","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2105\/AJPH.91.1.38","article-title":"Prevalence of hepatitis C among injection drug users in England and Wales: is harm reduction working?","volume":"91","author":"Hope","year":"2001","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0300","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1365-2893.2010.01297.x","article-title":"Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots","volume":"18","author":"Hope","year":"2011","journal-title":"J. Viral. Hepat."},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0085","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.drugpo.2011.05.007","article-title":"High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: findings from a population size estimation and respondent driven sampling survey","volume":"22","author":"Johnston","year":"2011","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0090","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0140-6736(00)04562-1","article-title":"Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis","volume":"357","author":"Kral","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0095","doi-asserted-by":"crossref","first-page":"e1000198","DOI":"10.1371\/journal.pmed.1000198","article-title":"The global spread of hepatitis C virus 1a and 1b: a phylodynamic and phylogeographic analysis","volume":"6","author":"Magiorkinis","year":"2009","journal-title":"PLoS Med."},{"issue":"Suppl. 5","key":"10.1016\/j.drugalcdep.2013.01.020_bib0100","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1097\/01.aids.0000343764.62455.9e","article-title":"Injecting and sexual risk behaviours, sexually transmitted infections and HIV prevalence in injecting drug users in three states in India","volume":"22","author":"Mahanta","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0235","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1753-6405.2007.00007.x","article-title":"High hepatitis C incidence in new injecting drug users: a policy failure?","volume":"31","author":"Maher","year":"2007","journal-title":"Aust. N. Z. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0105","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0140-6736(10)60232-2","article-title":"HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage","volume":"375","author":"Mathers","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0110","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1590\/S0074-02762004000800002","article-title":"The prevalence of human immunodeficiency virus type 1 and hepatitis C virus among injection drug users who use high risk inner-city locales in Miami, Florida","volume":"99","author":"McCoy","year":"2004","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0240","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/S0140-6736(02)08435-0","article-title":"Protection against persistence of hepatitis C","volume":"359","author":"Mehta","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0245","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2893.2005.00651.x","article-title":"Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies","volume":"13","author":"Micallef","year":"2006","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0250","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1053\/jhep.2002.35065","article-title":"Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users","volume":"36","author":"Miller","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0255","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/S0140-6736(06)68804-1","article-title":"Incidence of heroin use in Zurich, Switzerland: a treatment case register analysis","volume":"367","author":"Nordt","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0115","first-page":"CD007189","article-title":"Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals","volume":"7","author":"Okwundu","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0120","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1053\/j.gastro.2009.09.017","article-title":"Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection","volume":"138","author":"Osburn","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0260","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1086\/605947","article-title":"Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection","volume":"200","author":"Page","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0265","first-page":"889","article-title":"Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection","volume":"165","author":"Patrick","year":"2001","journal-title":"CMAJ"},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0125","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1086\/512815","article-title":"Impact of maternal HIV coinfection on the vertical transmission of hepatitis C virus: a meta-analysis","volume":"44","author":"Polis","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0270","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1097\/00002030-199714000-00012","article-title":"Pre-AIDS mortality from natural causes associated with HIV disease progression: evidence from the European Seroconverter Study among injecting drug users","volume":"11","author":"Prins","year":"1997","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0275","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/00365549609027145","article-title":"Incidence rate and risk factors for HCV seroconversion among injecting drug users in an area with low HIV seroprevalence","volume":"28","author":"Rezza","year":"1996","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0130","doi-asserted-by":"crossref","first-page":"F25","DOI":"10.1097\/00002030-200209060-00002","article-title":"Explosive spread and high prevalence of HIV infection among injecting drug users in Togliatti City, Russia","volume":"16","author":"Rhodes","year":"2002","journal-title":"AIDS"},{"issue":"Suppl. 8","key":"10.1016\/j.drugalcdep.2013.01.020_bib0135","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1097\/01.aids.0000304695.54884.4f","article-title":"Incidence of HIV, hepatitis C and hepatitis B viruses among injection drug users in southwestern China: a 3-year follow-up study","volume":"21","author":"Ruan","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0140","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF00146264","article-title":"Sexual transmission of hepatitis C virus and HIV-1 infection in female intravenous drug users","volume":"9","author":"Salvaggio","year":"1993","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0145","doi-asserted-by":"crossref","first-page":"iii7","DOI":"10.1093\/jurban\/jtg078","article-title":"The role of sexual transmission of HIV infection among injection and non-injection drug users","volume":"80","author":"Strathdee","year":"2003","journal-title":"J. Urban Health"},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0280","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1177\/0962280208094704","article-title":"Estimating the prevalence of ex-injecting drug use in the population","volume":"18","author":"Sweeting","year":"2009","journal-title":"Stat. Methods Med. Res."},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0150","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/jama.284.4.450","article-title":"The natural history of hepatitis C virus infection: host, viral, and environmental factors","volume":"284","author":"Thomas","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0285","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1111\/j.1360-0443.2011.03515.x","article-title":"The impact of needle and syringe provision and opiate substitution therapy on the incidence of Hepatitis C virus in injecting drug users: pooling of UK evidence","volume":"106","author":"Turner","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0155","series-title":"Tanzania Epidemiological Fact Sheet for HIV\/AIDS, 2009","author":"UNAIDS","year":"2011"},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0160","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF00146260","article-title":"A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam","volume":"9","author":"Van Ameijden","year":"1993","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0290","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1136\/bmj.317.7156.433","article-title":"Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study","volume":"317","author":"van Beek","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0295","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10654-006-9089-7","article-title":"Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users","volume":"22","author":"van Den Berg","year":"2007","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0165","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1093\/infdis\/jis213","article-title":"The more you look, the more you find: effects of hepatitis C virus testing interval on reinfection incidence and clearance and implications for future vaccine study design","volume":"205","author":"Vickerman","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0305","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/ije\/dyl276","article-title":"Modelling the impact of hepatitis C transmission on reducing syringe sharing: London case study","volume":"36","author":"Vickerman","year":"2007","journal-title":"Int. J. Epid"},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0170","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1360-0443.2009.02759.x","article-title":"Can HCV prevalence be used as a measure of injection-related HIV-risk in populations of injecting drug users? An ecological analysis","volume":"105","author":"Vickerman","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0175","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drugalcdep.2011.10.032","article-title":"Understanding the trends in HIV and hepatitis C prevalence amongst injecting drug users in different settings \u2013 implications for intervention impact","volume":"123","author":"Vickerman","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0180","doi-asserted-by":"crossref","first-page":"ii23","DOI":"10.1136\/sti.2008.034660","article-title":"Modelling the transmission of HIV and HCV amongst injecting drug users in Rawalpindi, a low HCV prevalence setting in Pakistan","volume":"85","author":"Vickerman","year":"2009","journal-title":"Sex. Transm. Infect."},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0185","first-page":"777","article-title":"A study on the prevalence rates of human immunodeficiency virus, hepatitis B virus and hepatitis C virus infections in intravenous drug users","volume":"27","author":"Wang","year":"2006","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0190","series-title":"WHO Drug Injecting Study \u2013 Phase II Operations Manual Version 4","author":"World Health Organisation","year":"2000"},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0195","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1086\/497131","article-title":"Risk factors for hepatitis C virus transmission to health care workers after occupational exposure: a European case\u2013control study","volume":"41","author":"Yazdanpanah","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2013.01.020_bib0200","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1590\/S0102-311X2006000400022","article-title":"HCV and HIV infection and co-infection: injecting drug use and sexual behavior, AjUDE-Brasil I Project","volume":"22","author":"Zocratto","year":"2006","journal-title":"Cad. Saude Publica"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871613000331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871613000331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T18:12:44Z","timestamp":1644430364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871613000331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":61,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0376871613000331"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2013.01.020","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}